Rotasiil-Liquid Oral Vaccine 2 ml belongs to the group of immunizing agents indicated in the prevention of rotavirus gastroenteritis caused by type G1, G2, G3, G4 and G9 in infants. Gastroenteritis is an inflammation of the gastric (stomach) mucosa characterised by vomiting, diarrhoea, abdominal cramps and fever.
Rotasiil-Liquid Oral Vaccine 2 ml contains Rotavirus vaccine-live attenuated that works by stimulating the production of antibodies against the attenuated Rotavirus specimen, thereby helping the immune system to provide protection against Rotavirus infection.
In some cases, Rotasiil-Liquid Oral Vaccine 2 ml may cause side effects such as irritability, vomiting, and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
Rotasiil-Liquid Oral Vaccine 2 ml is for oral use only, not for injection. Inform your doctor if the infant is immunocompromised or has gastrointestinal disorders. The safety and effectiveness of Rotasiil-Liquid Oral Vaccine 2 ml in infants less than six weeks and older than 32 weeks have not been established.